19
HK Inno.N
195940.KQ·KOSDAQSeoul KRFounded 20121,000 employees
Small CappharmaPublicGIOncology
Platform: K-CAB Tegoprazan
Market Cap
$1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (195940.KQ)
Loading 195940.KQ stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Gozefutibatinib | 195-6877 | Phase 1/2 | 1 | BET | T2DMM | ||
| 195-9888 | 195-9888 | Phase 1/2 | 2 | CD47 | PsA |
SEC Filings & Financial Documents
SEC filings are not available for KOSDAQ-listed companies.
HK Inno.N trades on KOSDAQ (KR). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)